NCT00014391
- Conditions
- Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +107 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
Clinical trial condition
Lymphoma, B-Cell, Marginal Zone
Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.
647 public trials
86 recruiting studies
Lymphoma, B-Cell, Marginal Zone trial results
NCT00003082
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Arizona Cancer Center Tucson, Arizona, United States
Completed
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00006042
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT00005580
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
- Locations
-
- New York Presbyterian Hospital - Cornell Campus New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Massey Cancer Center Richmond, Virginia, United States
NCT00210327
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland
NCT00373646
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Department of Internal Medicine I Vienna, Austria
NCT01947140
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +44 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States